The global demand for Whole Exome Sequencing Market is presumed to reach the market size of nearly USD 1808.36 Million by 2032 from USD 423.59 Million in 2023 with a CAGR of 17.5% under the study period 2024 - 2032.
Whole Exome Sequencing or Exome Sequencing is a next-generation sequencing method (NGS) used for sequencing of the protein-coding regions of the genome. Whole Exome Sequencing involves two steps - the first step is the selection of the subset of DNA, which encodes proteins, and the second step is the sequencing of the exonic DNA. The sequencing method is used in clinical diagnostics and academic research. It identifies genetic coding variants responsible for alteration in protein sequencing. Whole-genome sequencing is highly applicable in cancer research, understanding and identification of genetic variants causing genetic diseases, and understanding population genetics.
Market Dynamics
The global Whole Exome Sequencing market is expanding due to increasing awareness about genetic diseases such as Miller's syndrome and Alzheimer's disease. Whole Exome Sequencing is a cost-effective alternative for Whole-genome sequencing. Hence low cost and high speed are the two factors that are triggering the global Whole Exome Sequencing market. The other prominent factors that are driving the market include rising adoption for personalized medicine, growing cases of chronic diseases and growing R & D in genome sequencing. Moreover, factors such as advancement in technology, a growing number of innovative scientific applications, increasing investments by existing key players, and entry of new companies in the market are also propelling the market.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of whole exome sequencing.
Market Segmentation
The entire whole exome sequencing market has been sub-categorized into technology, products and services, applications and end users. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Product
- Instruments
- Consumables
- Services
By Technology
- Sequencing by Synthesis
- ION Semiconductor Sequencing
- Others
By Workflow
- Pre-Sequencing
- Sequencing
- Data Analysis
By Application
- Clinical Diagnostics
- Drug Discovery & Development
- Personalized Medicines
- Others
By End-use
- Academic And Research Institutes
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for whole exome sequencing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Whole Exome Sequencing Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Whole Exome Sequencing market include Thermo Fisher Scientific Inc., Illumina Inc, Agilent Technologies Inc, BGI, PacBio, Oxford Nanopore Technologies plc., Azenta US Inc. (GENEWIZ), CD Genomics, Novogene Co. Ltd., Eurofins Genomics. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.